Vasorelaxant effects of biochemical constituents of various medicinal plants and their benefits in diabetes

doi:10.4239/wjd.v15.i6.1122

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1153)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

125

HTML

565

Figures (1-4)

136

Tables (1-2)

112

Sum=938

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

131

Sum=167

Jun 15, 2024 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Jun 15, 2024; 15(6): 1122-1141
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1122

Open in New Tab Full Size Figure Download Figure

Figure 1 Vasorelaxation effect of nitric oxide-cyclic guanosine monophosphate pathway. cGMP: Cyclic guanosine monophosphate; EC: Endothelial cell; eNOS: Endothelial nitric oxide synthase; NO: Nitric oxide; sGC: Soluble guanylate cyclase; VSMC: Vascular smooth muscle cell.

Open in New Tab Full Size Figure Download Figure

Figure 2 Vasorelaxation effect of PGI₂-cyclic adenosine monophosphate pathway. AC: Adenylyl cyclase; ARA: Arachidonic acid; cAMP: Cyclic adenosine monophosphate; COX: Cyclooxygenase; EC: Endothelial cell; PGI₂: Prostacyclin; IP: Prostacyclin receptor; PGIS: Prostacyclin synthase; PGH₂: Prostaglandin H₂; VSMC: Vascular smooth muscle cell.

Open in New Tab Full Size Figure Download Figure

Figure 3 Vasorelaxation effect of phosphodiesterases inhibition. cGMP: Cyclic guanosine monophosphate; EC: Endothelial cell; eNOS: Endothelial nitric oxide synthase; 5’-GMP: 5’-Guanylic acid; NO: Nitric oxide; PDE: Phosphodiesterase; sGC: Soluble guanylate cyclase; VSMC: Vascular smooth muscle cell.

Open in New Tab Full Size Figure Download Figure

Figure 4 Vasorelaxation effect of opening K⁺ ion channels/reduction of Ca²⁺ levels in the cell. EC: Endothelial cell; MH: Membrane hyperpolarization; VSMC: Vascular smooth muscle cell.

Citation: Demirel S. Vasorelaxant effects of biochemical constituents of various medicinal plants and their benefits in diabetes. World J Diabetes 2024; 15(6): 1122-1141
URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1122.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1122